Tazeen Ahmad

Stock Analyst at B of A Securities

(1.51)
# 1825
Out of 5,443 analysts
253
Total ratings
Success rate
Average return
56 Stocks
Name Action PT Current % Upside Ratings Updated
BNTX BioNTech
Maintains: Strong Buy
126 134
109.29 22.61% 9 Aug 5, 2025
PTCT PTC Therapeutics
Maintains: Strong Buy
68 84
43.3 94% 16 Jul 29, 2025
SRPT Sarepta Therapeutics
Downgrades: Underperform
20 10
17.95 -44.29% 24 Jul 23, 2025
APLS Apellis Pharmaceutic...
Maintains: Neutral
23 24
23.87 0.54% 8 Jul 16, 2025
ALNY Alnylam Pharmaceutic...
Maintains: Strong Buy
336 359
434.89 -17.45% 4 Jul 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
2.75 190.91% 1 Jul 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
73 95
94.32 0.72% 9 Jul 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 15
8.2 82.93% 7 Jul 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
201 216
195.94 10.24% 10 Jun 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
18 23
24.83 -7.37% 15 Jun 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
22 4
7.67 -47.85% 6 May 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
1 1
0.77 3.9% 3 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
28 27
13.91 94.1% 3 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
54 28
6.58 325.53% 2 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
73 70
64.6 8.36% 5 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 40
5.53 623.33% 4 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
184 179
123.99 44.37% 5 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
12.52 75.72% 1 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6 3
1.01 197.03% 3 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
68 90
79.21 13.62% 5 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 15
6.66 125.23% 5 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
11 6
8.68 -30.88% 14 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
10 2
6.35 -68.5% 6 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
535 607
638.76 -4.97% 3 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
83 76
27.39 177.47% 6 May 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
16 14
4 250% 2 Apr 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 10
2.35 325.53% 4 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
2 6
0.94 538.3% 2 Mar 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
12.56 19.43% 1 Feb 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
3
3.02 -0.66% 2 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
7 1
1.48 -66.22% 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
8 11
20.55 -46.47% 3 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
36 31
44.96 -31.05% 2 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
7 2
2.67 -25.09% 2 Apr 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
2 7
n/a n/a 3 Feb 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
90 20
n/a n/a 2 Dec 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6
0.82 631.71% 4 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
75 15
10 50% 3 Nov 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
390 60
44.96 33.45% 2 Jun 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
23
n/a n/a 2 May 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
16
1.05 1423.81% 1 Nov 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 2 Oct 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
24 20
13.29 50.49% 2 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
13 5
0.87 474.71% 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
43
8.76 390.87% 2 Sep 25, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 47
n/a n/a 2 Aug 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
6
n/a n/a 4 Apr 9, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
233 227
n/a n/a 4 Feb 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 3 Sep 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 4 Apr 25, 2019